Top Markets
#1 Gama Token Gama Token +8.43%
#2 Cross Cross +4.60%
#3 Holoworld Holoworld +3.83%
#4 Nexpace Nexpace +3.75%
#5 Cryptopia Cryptopia +3.24%
#6 Tutorial Tutorial +3.07%
#7 Perle Perle +3.00%
#8 The Innovation Game The Innovation Game +2.94%
#9 Berachain Berachain +2.86%
#10 Fake World Assets Fake World Assets +2.84%
Coin of the day
Gama Token Gama Token
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Pozycja w akcjach #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Cena akcji
$0.14966934
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$3.02M
Zmiana (1 dzień)
3.72%
Zmiana (1 rok)
-93.70%
Kraj
SE
Handel Guard Therapeutics International AB (publ) (GUARD)

Kategoria

Healthcare
Zyski dla Guard Therapeutics International AB (publ) (GUARD)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Guard Therapeutics International AB (publ), obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Guard Therapeutics International AB (publ) od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE